KEAP1 and rheumatoid arthritis: Thus, we propose that lowly expressed LncRNA DANCR ameliorates the immune inflammatory response in RA by sponging miR‐134‐5p to activate its mediated Keap1‐Nrf2/ARE signaling pathway, inhibiting the release of inflammatory factors from RA‐FLS and stimulating antioxidant capacity (Figure 8).